GlassScriptPhysician profile
Yamira Bordas
NPI 1518455633
$5,137.20
in general payments reported to CMS, 2019-2025
41 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 93% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,066 · 2022: $614 · 2024: $1,284 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,275 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.05 |
| Education | $181.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,158.73 | 2021-2025 | Fintepla, Briviact, Nayzilam |
| Neurelis, INC. | $701.74 | 2021-2025 | Valtoco |
| Corium, LLC | $459.48 | 2021-2025 | Azstarys |
| Tris Pharma INC | $369.28 | 2021-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $347.50 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $291.35 | 2021-2025 | Qelbree |
| Jazz Pharmaceuticals INC. | $182.41 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $151.03 | 2024-2025 | |
| Eisai INC. | $118.07 | 2021-2024 | |
| Pfizer INC. | $115.88 | 2024 | |
| Sunovion Pharmaceuticals INC. | $111.06 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $106.08 | 2025 | Daybue |
| Incyte Corporation | $105.21 | 2024 | Jakafi |
| Takeda Pharmaceuticals U.S.A., INC. | $84.27 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $66.53 | 2024 | Keytruda, Lynparza |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yamira Bordas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.